Approved for Maintenance treatment of COPD including chronic bronchitis and/or emphysema. Triple therapy combining budesonide (ICS), glycopyrrolate (LAMA), and formoterol (LABA) in a single inhaler. Provides anti-inflammatory, anticholinergic, and beta-2 agonist bronchodilation. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and…
Loading full data from Know Your Drugs Institute…